Arkolith/Insider Trading/CMMB/Form 4

Marvin Donald

Executive VP, CFO & COOChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 21, 2022
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2022Buy(P)250$3.90$9751K
Mar 14, 2022Buy(P)250$4.10$1K1K
Mar 14, 2022Buy(P)250$4.20$1K2K
Mar 14, 2022Buy(P)250$4.00$1K250
Mar 14, 2022Buy(P)250$3.98$995500

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2021Grant(A)197K—$0197K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-001179) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML